Global Cardiovascular Surgical Devices and Technologies Market Growth 2023-2029

Global Cardiovascular Surgical Devices and Technologies Market Growth 2023-2029

Cardiovascular surgery is the process performed to cure the heart tissue defects such as replacing the diseased heart valves if it is blocked, grafting or replacement of heart tissues in case of damage.

LPI (LP Information)' newest research report, the “Cardiovascular Surgical Devices and Technologies Industry Forecast” looks at past sales and reviews total world Cardiovascular Surgical Devices and Technologies sales in 2022, providing a comprehensive analysis by region and market sector of projected Cardiovascular Surgical Devices and Technologies sales for 2023 through 2029. With Cardiovascular Surgical Devices and Technologies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cardiovascular Surgical Devices and Technologies industry.

This Insight Report provides a comprehensive analysis of the global Cardiovascular Surgical Devices and Technologies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cardiovascular Surgical Devices and Technologies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Cardiovascular Surgical Devices and Technologies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cardiovascular Surgical Devices and Technologies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cardiovascular Surgical Devices and Technologies.

The global Cardiovascular Surgical Devices and Technologies market size is projected to grow from US$ 1369 million in 2022 to US$ 1787.2 million in 2029; it is expected to grow at a CAGR of 1787.2 from 2023 to 2029.

United States market for Cardiovascular Surgical Devices and Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cardiovascular Surgical Devices and Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cardiovascular Surgical Devices and Technologies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cardiovascular Surgical Devices and Technologies players cover Abbott Cardiovascular, Abiomed, Boston Scientific, C.R. Bard, Abbott, Thoratec Laboratories, Transmedics, Cook Medical and Cordis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Surgical Devices and Technologies market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Beating Heart Surgery Systems
Perfusion Disposables
CPB Equipment
Cardiac Ablation Devices

Segmentation by application
Hospital
Academic And Medical Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Cardiovascular
Abiomed
Boston Scientific
C.R. Bard
Abbott
Thoratec Laboratories
Transmedics
Cook Medical
Cordis
Angiodynamics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cardiovascular Surgical Devices and Technologies market?

What factors are driving Cardiovascular Surgical Devices and Technologies market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cardiovascular Surgical Devices and Technologies market opportunities vary by end market size?

How does Cardiovascular Surgical Devices and Technologies break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.